November 20, 2009
TAIPEI, Taiwan Regular consumption of kiwifruit might exert beneficial effects on the antioxidative status and the risk factors for cardiovascular disease (CVD) in hyperlipidemic subjects (Int J Food Sci Nutr. 2009;60(8):709-716). A total of 43 subjects with hyperlipidemia, including 13 males and 30 females were asked to consume two kiwifruit per day for eight weeks. No significant differences from baseline to eight weeks of the intervention were detected for triacylglycerol, total cholesterol, or LDL cholesterol. However, after eight weeks of consumption of kiwifruit, the high-density lipoprotein (HDL) concentration was significantly increased and the low-density lipoprotein (LDL) cholesterol /HDL ratio and total cholesterol/HDL ratio were significantly decreased. Vitamin C and vitamin E also increased significantly. In addition, the lag time of LDL oxidation and malondialdehyde + 4-hydroxy-2(E)-nonenal had significantly changed at four and eight weeks during the kiwifruit intervention.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023